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Background. Dobutamine stress myocardial perfusion imaging (MPI) is a useful alternative
for the evaluation of coronary artery disease (CAD) in elderly patients who are unable to
perform an exercise stress test. However, data on the long-term prognostic value of stress MPI
in elderly patients are lacking. Therefore, this study evaluated the long-term prognostic value of
dobutamine stress MPI in elderly patients unable to perform an exercise test.
Methods. The study population consisted of 247 elderly patients (mean age 71 ± 5 years)
who underwent dobutamine stress single-photon emission computed tomography (SPECT)
MPI. An abnormal SPECT study was defined as the presence of fixed and/or reversible per-
fusion defects. A summed stress score (SSS) was obtained to estimate the extent and severity of
perfusion defects. End points during follow-up were all-cause mortality, cardiac mortality, and
nonfatal myocardial infarction (MI).
Results. During a median follow-up of 14 years (range 12-16), 168 (68%) patients died (all-
cause mortality), of which 56 (23%) were due to cardiac causes. Nonfatal MI occurred in 19
(8%) patients. Kaplan-Meier survival curves showed that MPI provided optimal risk stratifi-
cation in patients with normal and abnormal MPI. Multivariable analysis identified an
abnormal MPI as a strong significant predictor of all-cause mortality and cardiac events. A
multivariable analysis also revealed that a reversible defect and SSS were strong long-term
predictors of cardiac mortality and hard cardiac events.
Conclusion. Dobutamine stress 99mTc-tetrofosmin SPECT provides incremental prognostic
information for the prediction of long-term cardiovascular outcomes in elderly patients, unable
to perform exercise testing. Dobutamine stress MPI is useful in risk classifying elderly patients.
(J Nucl Cardiol 2016)
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Abbreviations
ACE Angiotensin converting enzyme
CABG Coronary artery bypass graft surgery
CAD Coronary artery disease
ECG Electrocardiography
MI Myocardial infarction
MPI Myocardial perfusion imaging
LBBB Left bundle branch block
PCI Percutaneous coronary intervention
SPECT Single-photon emission computed
tomography
SSS Summed stress score
INTRODUCTION
Globally, deaths from cardiovascular disease are
increasing, in particular, due to the aging population.
Between 1990 and 2013, the number of global deaths
caused by cardiovascular disease has increased by 41%.1
As a result of aging of the population, more elderly
patients are referred for diagnostic and prognostic
cardiac evaluation. Stress myocardial perfusion imaging
(MPI) is useful for the evaluation of coronary artery
disease (CAD) in elderly patients.2,3 A substantial
proportion of the elderly population is unable to perform
exercise stress testing, because of conditions such as
degenerative joint disease or peripheral vascular disease.
In such patients, vasodilator stress testing is a useful
alternative. In patients who also have contraindications
for vasodilator stress (such as reactive airway disease or
high-grade atrioventricular nodal block), dobutamine
stress MPI is recommended according to the ASNC
imaging guidelines for nuclear cardiology.4 The prog-
nostic value of MPI using single-photon emission
computed tomography (SPECT) with 99mTc-tetrofosmin
or 99mTc-sestamibi as tracers in elderly patients has been
studied previously for short- and medium-term follow-
up.5-9 Long-term prognostic data to define the role of
stress MPI for the prediction of cardiovascular outcomes
in elderly patients are lacking. The long-term prognostic
value of stress MPI in elderly patients may be impaired
because of their increased underlying cardiovascular
risk. Accordingly, the aim of the current study was to
assess the long-term prognostic value of dobutamine
stress 99mTc-tetrofosmin MPI for the prediction of
cardiovascular outcomes in elderly patients unable to
perform exercise testing.




This study included 272 consecutive elderly patients
C65 years old who were unable to perform exercise testing
and underwent dobutamine stress 99mTc-tetrofosmin SPECT
for the evaluation of suspected or known CAD. The age cut-off
was based on previous studies.3,10 The current study is a
continuation of a previous study 8 in which this population of
elderly patients was evaluated with a mean follow-up of
3 years The reason to perform the current follow-up study was
to assess the very long-term prognostic value of dobutamine
stress SPECT. At the time of this study, dobutamine was the
preferred stressor in our nuclear cardiology laboratory, and the
mode of stress was determined by the referring physician.
Patients were enrolled between 1995 and 1999. Follow-up was
complete for 270 (99.3%) patients. Twenty-three patients
underwent coronary artery revascularization \60 days of the
test and were excluded. This exclusion was based on previous
data indicating that in the first 60 days after the test, referral
for coronary artery revascularization tends to be based on the
SPECT results, whereas [60 days after testing, referral for
coronary artery revascularization tends to be based on dete-
rioration of the patient’s clinical status.11 The present data are
based on 247 patients. This study was not subject to the Dutch
Medical Research Involving Human Subjects Act.12,13 There-
fore, approval from the local research ethics committee to
conduct this retrospective study was not required at the time of
enrollment. Moreover, the study was conducted according to
the Declaration of Helsinki.14 All patients consented partici-
pation in this study.
Clinical Data
Before dobutamine stress testing, a structured clinical
interview and history were acquired, and cardiac risk factors
were assessed. Hypertension was defined as a blood pressure
C140/90 mmHg or treatment with antihypertensive medica-
tion. Diabetes mellitus was defined as a fasting glucose level
C7.8 mmolL-1 or the need for insulin or oral hypoglycemic
medication. Hypercholesterolemia was defined as a total
cholesterol C6.4 mmolL-1 or treatment with lipid-lowering
medication.
Dobutamine Stress Testing
Dobutamine stress testing was performed according to a
standard protocol as previously reported.15 Dobutamine was
infused through the antecubital vein, starting with a dose of
10 lgkg-1min-1 for 3 minutes and being increased by
10 lgkg-1min-1 every 3 minutes up to a maximum dose of
40 lgkg-1min-1. If the test endpoint was not reached at a
dobutamine dose of 40 lgkg-1min-1, atropine (up to 1 mg)
was given intravenously. Blood pressure and heart rate were
monitored, and electrocardiography was recorded constantly.
Test endpoints were achievement of target heart rate (85% of
maximum age- and sex-predicted heart rate); horizontal or
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downsloping ST-segment depression[2 mm at an interval of
80 ms after the J-point, compared with baseline; ST-segment
elevation [1 mm in patients without previous myocardial
infarction; severe angina; a systolic blood pressure fall
[40 mm Hg, compared with baseline; blood pressure [240/
120 mmHg; or significant cardiac arrhythmias. Metoprolol was
available to reverse the adverse effects of dobutamine/atropine.
99mTc-Tetrofosmin SPECT MPI
Approximately 1 min before the termination of the
dobutamine stress test, an intravenous dose of 370 MBq of
99mTc-tetrofosmin was administered. For resting studies,
370 MBq of tetrofosmin were injected at least 24 hours after
the stress study. Image acquisition was performed with a triple-
head c-camera system (Prism 3000 XP; Picker International).
For each study, six oblique (short axis) slices from the apex to
the base and three sagittal (vertical long axis) slices were
defined. Each of the six short-axis slices was divided into eight
equal segments. Owing to correspondence of the septal part of
the two basal slices to the fibrous portion of the interventricular
septum and normally exhibits reduced uptake, this region was
excluded from analysis. As a consequence, 47 segments were
identified (3 long axis and 44 short axis). The interpretation of
the scan was semiquantitatively performed by visual analysis
and aided by circumferential profiles analysis. Stress and rest
tomographic views were reviewed side by side by an experi-
enced observer who had no knowledge of the patients’ clinical
information. A reversible perfusion defect was defined as a
perfusion defect on the exercise images that partially or
completely resolved at rest in C2 contiguous segments or
slices. A fixed perfusion defect was defined as a perfusion
defect on exercise images in two or more contiguous segments
or slices, which persists on rest images. The presence of a fixed
and/or reversible perfusion defect was considered as an
abnormal study. Each myocardial segment was assigned a
score from 0 to 3 (0 = normal; 1 = slightly reduced;
2 = moderately reduced; 3 = severely reduced or absent
uptake). Summed stress score (SSS) was calculated by the
summation of the scores of the myocardial segments at stress.
Standard 17-segment-based scores were calculated and con-
verted to percent of the total myocardium (% myocardium) by
dividing the summed scores by the maximum potential score,
and multiplying by 100.16
Patient Follow-up
Collection of follow-up data was performed by contacting
the patient, the patient’s general practitioner, civil registries,
and review of hospital records. Follow-up data were obtained
in September 2011. The date of the last review or consultation
was used to determine follow-up time. Endpoints were all-
cause mortality, cardiac mortality, and nonfatal myocardial
infarction (MI). Causes of death were obtained from the
Central Bureau of Statistics Netherlands. Cardiac mortality
was defined as death caused by myocardial infarction, signif-
icant cardiac arrhythmias, or refractory congestive heart
failure. Sudden death occurring without another explanation
was included as cardiac mortality. Nonfatal MI was described
by chest pain complaints, the rise and fall of cardiac marker
levels and typical changes on electrocardiography (ECG).
Hard cardiac events were defined as the occurrence of cardiac
mortality or nonfatal MI.
Statistical Analysis
Continuous data were expressed as mean ± SD, and
percentages were rounded. Continuous variables were com-
pared using the Student t test for unpaired samples. The
cumulative survival was calculated using the Kaplan-Meier
method. Survival curves were compared with the log-rank test.
Univariable and multivariable Cox proportional hazards
regression models were used to investigate the additional
value of MPI parameters. The risk of a variable was expressed
as a hazard ratio (HR) with a corresponding 95% confidence
interval. First, clinical data were selected in a stepwise forward
selection manner with entry and retention set of a significance
level of 0.05. Significant clinical data were then used for
including in the multivariable analysis. The incremental value
of MPI over the clinical variables in the prediction of events
was determined according to 3 models. In Model 1, the
incremental values of abnormal MPI over the clinical data and
stress test information were assessed. In Model 2, the presence
of a fixed or reversible defect was entered. In Model 3, the SSS
was entered. A P value\ .05 was considered statistically
significant.
RESULTS
Demographics and Stress Test Results
Clinical characteristics of the 247 patients are
presented in Table 1. The mean age of the study
population was 71 ± 5 years (range 65 and 86 years).
A total of 48 patients (19%) were [75 years old.
Dobutamine stress increased heart rate significantly
(from 72 ± 15 to 128 ± 16 bpm, P\ .001) and
increased systolic blood pressure modestly (from
140 ± 23 to 146 ± 31 mm Hg, P\ .001). The highest
dobutamine dose was 10 lgkg-1min-1 in 1 patient
(0.4%), 20 lgkg-1min-1 in 44 (18%), 30 lgkg-1min-1
in 45 (18%), and 40 lgkg-1min-1 in 157 (64%). In 88
patients (36%), atropine was added. Patients who were
using beta blocker therapy during the dobutamine stress
test more frequently received atropine than did patients
not receiving beta blocker therapy (54 of 105, 51%, vs
34 of 142, 24%, P\ .001). A total of 181 patients (73%)
achieved target heart rate. Achieving the target heart rate
was not significantly different between patients with and
without cardiac mortality (79 vs 72%, P = .96) and hard
cardiac events (75 vs 80%, P = .42).
Side effects that occurred during dobutamine stress
testing were generally self-limiting. These included
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atrial fibrillation in 5 patients (2%), short ventricular
tachycardia (\10 complexes) in 6 patients (2.4%), and
severe hypotension (decrease in systolic blood pressure
[40 mm Hg) in 4 patients (1.6%). Minor side effects
included nausea in 4 (1.6%), flushing in 3 (1.2%), and
headache in 13 (5.3%). No patient experienced a
myocardial infarction or ventricular fibrillation during
or immediately after the stress test.
SPECT Results and Outcome
Abnormal MPI was detected in 140 patients (57%).
A total of 20 (8%) patients showed reversible defects, 67
patients (27%) showed a fixed defect, while 53 patients
(22%) showed both fixed and reversible defects. During
a median follow up of 14 years (range 12-16), 168
(68%) patients died (all-cause mortality), of which 56
(23%) were due to cardiac causes. Nonfatal MI occurred
in 19 (8%) patients. The Kaplan-Meier survival curves
are shown in Figures 1, 2, and 3. The survival curves
show that a normal MPI was associated with relatively
low risk of all-cause mortality, cardiac mortality, and
hard cardiac events. Conversely, elderly patients with an
abnormal MPI had a significantly increased risk of all-
cause mortality and cardiac events.
Predictors of Outcome
Univariable and multivariable predictors of all-
cause mortality, cardiac mortality, and hard cardiac
events are shown in Tables 2, 3, and 4, respectively.




Age (years) 71 ± 5
Male gender 129 (52)
Hypertension 102 (41)
Diabetes mellitus 47 (19)
Smoking 52 (21)
Hypercholesterolemia 74 (30)
Heart failure 40 (16)
LBBB 15 (6)
Beta blockers 105 (43)
Calcium channel blockers 111 (45)




History of myocardial infarction 89 (36)
History of coronary angioplasty 44 (18)




LBBB left bundle branch block


























Figure 1. Kaplan-Meier survival curves for all-cause
mortality.


























Figure 2. Kaplan-Meier survival curves for cardiac mortality.

























Figure 3. Kaplan-Meier survival curves for hard cardiac
events (cardiac mortality and nonfatal myocardial infarction).
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Table 2. Univariable and multivariable predictors of all-cause mortality
Variable Univariable
Multivariable
Clinical data Model 1 Model 2 Model 3
Men 1.84 (1.30–2.61) 1.69 (1.19–2.38) P = .12 P = .07 1.49 (1.02–2.19)
Prior MI P = .50 P = .43 – – –
Diabetes mellitus 1.58 (1.05–2.38) P = .07 – – –
Hypertension 1.88 (1.34–2.64) 1.76 (1.25–2.46) 1.83 (1.29–2.60) 1.77 (1.25–2.51) 1.72 (1.21–2.45)
Hypercholesterolemia P = .97 P = .66 – – –
Smoking 1.49 (1.01–2.20) P = .06 – – –
Heart failure 1.99 (1.32–3.01) 1.75 (1.16–2.65) 1.72 (1.13–2.61) 1.69 (1.10–2.57) 1.63 (1.06–2.51)
Stress test results
Angina pectoris P = .46 – P = .19 P = .28 P = .24
ST-segment changes P = .41 – P = .99 P = .80 P = .75
Peak heart rate P = .37 – P = .19 P = .60 P = .64
Scan parameters
Abnormal MPI 1.76 (1.24–2.51) – 1.79 (1.22–2.64) – –
Fixed defect P = .14 – – P = .09 –
Reversible defect 1.76 (1.24–2.51) – – 1.64 (1.13–2.38) –
SSS* 1.20 (1.11–1.38) – – – P = .11
Statistically significant predictors of outcome are presented as hazard ratio (confidence interval), of all other variables the P value
is presented.
– not included in the model, * per % myocardium increment, MI myocardial infarction, MPI myocardial perfusion imaging,
SSS summed stress score
Table 3. Univariable and multivariable predictors of cardiac mortality
Variable Univariable
Multivariable
Clinical data Model 1 Model 2 Model 3
Men P = .16 P = .31 – – –
Prior MI P = .51 P = .63 – – –
Diabetes mellitus 2.17 (1.22–3.89) P = .07 – – –
Hypertension 2.55 (1.19–4.37) 2.43 (1.42–4.17) 2.41 (1.40–4.17) 2.28 (1.32–3.92) 2.32 (1.34–4.01)
Hypercholesterolemia P = .47 P = .60 – – –
Smoking P = .25 P = .09 – – –
Heart failure 2.79 (1.56–4.99) 2.60 (1.45–4.65) 2.39 (1.32–4.30) 2.37 (1.31–4.27) 2.18 (1.19–4.00)
Stress test results
Angina pectoris P = .93 – P = .65 P = .88 P = .70
ST-segment changes P = .50 – P = .53 P = .76 P = .76
Peak heart rate P = .87 – P = .99 P = .90 P = .96
Scan parameters
Abnormal MPI 2.23 (1.26–3.94) – 2.49 (1.39–4.48) – –
Fixed defect P = .34 – – P = .17 –
Reversible defect 1.94 (1.14–3.33) – – 1.92 (1.11–3.33) –
SSS* 1.11 (1.00–1.12) – – – 1.09 (1.01–1.18)
Statistically significant predictors of outcome are presented as hazard ratio (confidence interval), of all other variables the P value
is presented.
– not included in the model, * per % myocardium increment, MI myocardial infarction, MPI myocardial perfusion imaging,
SSS summed stress score
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Among clinical variables, men, diabetes mellitus, hyper-
tension, smoking, and heart failure were significant
predictors of all-cause mortality (Table 2). Diabetes
mellitus, hypertension, and heart failure were significant
predictors of cardiac mortality (Table 3). Men, diabetes
mellitus, hypertension, and heart failure were univari-
able predictors of hard cardiac events (Table 4). A
multivariable model revealed that an abnormal MPI and
reversible defect were powerful predictors of all-cause
mortality (Table 2). A multivariable analysis also
revealed that an abnormal MPI, reversible defect and
SSS provided incremental prognostic information over
that provided by clinical and stress test variables for
predicting cardiac mortality (Table 3) and hard cardiac
events (Table 4).
DISCUSSION
The main finding of this study is that dobutamine
stress 99mTc-tetrofosmin SPECT provides long-term
prognostic information for the prediction of all-cause
mortality and cardiac events in elderly patients unable to
perform exercise testing. Dobutamine stress MPI pro-
vided prognostic information incremental to clinical
data and stress test results. Patients with a normal MPI
had a relatively favorable long-term prognosis, in
contrast to patients with an abnormal study who had a
significantly increased risk of all-cause mortality and
cardiac events. An abnormal MPI and the scan result
reversible perfusion defect were strong significant pre-
dictors of all-cause mortality and cardiac events. Also
the SSS was a strong long-term predictors of cardiac
mortality and hard cardiac events.
In the aging population, CAD is a major health
problem, and cardiovascular disease is still the leading
cause of mortality in elderly patients.17 As a result, elderly
patients with known or suspected CAD are frequently
encountered in a nuclear cardiology practice. Stress MPI
is an important noninvasive technique for the evaluation
of patients with known or suspected CAD. Elderly
patients are frequently unable to perform an exercise test
due to several comorbidities (e.g. obstructive lung dis-
ease, peripheral vascular disease). Dobutamine stress MPI
is a feasible alternative for these patients and also for
patients who have contraindications for vasodilator
(dipyridamole or adenosine) stress testing.3 The present
study included 247 elderly patients unable to perform an
exercise test. We found that dobutamine stress MPI had
incremental long-term prognostic value additional to
clinical variables and stress test results.
Several previous studies have evaluated the short or
medium-term prognostic value of SPECT MPI in elderly
Table 4. Univariable and multivariable predictors of hard cardiac events.
Variable Univariable
Multivariable
Clinical data Model 1 Model 2 Model 3
Men 1.70 (1.04–2.76) P = .07 – – –
Prior MI P = .73 P = .83 – – –
Diabetes mellitus 1.76 (1.01–3.05) P = .19 – – –
Hypertension 2.31 (1.42–3.75) 2.24 (1.38–3.63) 2.16 (1.32–3.54) 2.02 (1.24–3.31) 2.00 (1.22–3.29)
Hypercholesterolemia P = .43 P = .59 – – –
Smoking P = .28 P = .14 – – –
Heart failure 2.24 (1.29–3.89) 2.11 (1.22–3.67) 1.90 (1.09–3.32) 1.90 (1.09–3.31) P = .05
Stress test results
Angina pectoris P = .77 – P = .47 P = .65 P = .54
ST-segment changes P = .48 – P = .31 P = .91 P = .95
Peak heart rate P = .41 – P = .31 P = .44 P = .34
Scan parameters
Abnormal MPI 2.32 (1.38–3.91) – 2.72 (1.59–4.66) – –
Fixed defect P = .13 – – P = .05 –
Reversible defect 1.79 (1.10–2.93) – – 1.85 (1.12–3.04) –
SSS* 1.11 (1.01–1.12) – – – 1.09 (1.02–1.18)
Statistically significant predictors of outcome are presented as hazard ratios (confidence interval), of all other variables the P value
is presented.
– not included in the model, * per % myocardium increment, MI myocardial infarction, MPI myocardial perfusion imaging,
SSS summed stress score.
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patients with a follow-up duration ranging from 4.4 to
6.4 years. Steingart et al.5 studied 578 patients aged
65 years or older (mean age 70.7 ± 4.4 years) who
underwent exercise MPI. A multivariable model
revealed that age, male gender, limitation of exercise
tolerance, and the number of ischemic segments on MPI
were significant predictors of death or MI. The authors
concluded that an abnormal MPI provided prognostic
information during the 4-year follow-up period. Valeti
et al.6 followed 247 elderly patients with a mean age of
77 years undergoing exercise thallium-201 MPI. A total
of 42 (17%) patients had a history of CAD (history of
MI) compared to 89 (36%) patients in the current study.
Also, patients without a previous percutaneous coronary
intervention (PCI) or coronary artery bypass graft
surgery (CABG) were included, while in the current
study 37% had a previous coronary revascularization. In
that study of Valeti et al.,6 exercise MPI was accurate
for risk stratification in elderly patients who were able to
exercise during a median follow-up duration of
6.4 years.
A total of three studies have assessed the short- to
medium-term cardiovascular outcomes after pharma-
cological stress MPI. De Winter et al.7 studied cardio-
vascular outcomes in a total of 294 patients (median age
78 years) that underwent exercise (n = 103) or dipyri-
damole stress (n = 191) 99mTc-tetrofosmin SPECT.
During a median follow-up of 25.9 months 47 deaths
occurred of whom 27 cardiac deaths. The summed rest
score (SRS) was a significant predictor of all-cause
mortality and cardiac mortality. The authors concluded
that gated SPECT provided independent and incre-
mental information above clinical and perfusion SPECT.
Nagao et al.9 studied the outcomes of 175 patients (aged
75-85 years) that underwent exercise (n = 49) or
vasodilator stress (n = 126) 99mTc-sestamibi SPECT.
A total of 64 patients (37%) had a previous MI or
coronary revascularization compared to 73% in the
current study. During a mean follow-up of 3.4 years,
SPECT results were predictive of cardiovascular out-
comes. The results of those studies are in line with the
current study, in that elderly patients with a normal
SPECT have a relative good prognosis compared to
patients with an abnormal SPECT who have an
increased risk of all-cause mortality and cardiac
events. In those studies, the maximum follow-up
duration was limited to 6.4 years. Schinkel et al.8
has described the 3.3 years cardiovascular outcomes of
this cohort of 247 elderly patients. Dobutamine stress
99mTc-tetrofosmin SPECT provided incremental prog-
nostic information for the prediction of total mortality
and cardiac events. However, no data exist on the
long-term prognostic value of pharmacologic stress
MPI. The present study extends the observations
drawn from these previous studies and demonstrates
the long-term prognostic value of dobutamine stress
MPI in elderly patients.
More recently, Kwon et al.18 studied a Medicare
cohort including 5,994 patients (age[ 65 years) who
underwent exercise (n = 1,664) or adenosine stress
(n = 4,280) MPI. During a median follow-up of
2.4 years, the ability to exercise and the number of
METs achieved were predictive of outcome. Among
patients who were able to perform an exercise test, MPI
did not provide incremental significant risk stratifica-
tion. Several factors may explain why the findings in
the study of Kwon et al. differ from the current
findings. First, the current study included only patients
who were unable to perform an exercise test, which is a
marker of an adverse outcome in itself. Second, this
study included a substantial number of patients with
known CAD (36% had a previous myocardial infarc-
tion, 18% had previous coronary angioplasty, and 19%
had previous coronary bypass surgery). Third, this
study had a long-term and nearly complete follow-up
which included information from the patient, the
general practitioner, civil registries, and review of
hospital records. The all-cause mortality rate during the
long-term follow-up in the current study was 68% vs
6% during the median follow-up of 2.4 years in the
previous study of Kwon et al. All these factors could
have influenced the outcomes.
SPECT MPI is routinely used in conjunction with
both 99mTc-sestamibi and 99mTc-tetrofosmin as tracers.
The latter is used in the current study. Multiple studies
have reported the prognostic value of 99mTc-sestamibi
during dobutamine19,20 or adenosine induced stress21 in
various patient subsets. In a previous study of our center,
473 patients were studied who underwent dobutamine
stress 99mTc-sestamibi SPECT and were followed for a
mean follow-up of 819 and 11 years.20 A total of 44% of
the patients had a previous MI and 35% had undergone
previous revascularization. A total of 312 (66%) patients
had abnormal MPI, defined as the presence of a fixed
and/or reversible perfusion defect. The incremental
prognostic value of dobutamine stress SPECT was
maintained during a follow-up duration of 11 years. In
the present long-term follow-up study, elderly patients
with normal MPI had a maintained favorable event-free
survival compared to patients with abnormal MPI. So,
the present findings are consistent with these previous
studies. Also, Hachamovitch et al.21 studied 684 elderly
patients (mean age 80.3 ± 4.1 years) who underwent
99mTc-sestamibi SPECT MPI. Of the 684 patients, 26%
had a previous MI and 30% had prior revascularization.
During a mean follow-up of 6 years, cardiac mortality
rates were significant lower in patients with normal MPI
in contrast to patients with abnormal MPI. The findings
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of the current study extends the conclusions drawn from
this study.
NEW KNOWLEDGE GAINED
Stress 99mTc-tetrofosmin MPI provides incremental
prognostic information for the prediction of 14-year
cardiovascular outcomes in elderly patients unable to
perform exercise testing. Information on the presence,
severity, and extent of perfusion abnormalities can be
used for risk stratification of this high-risk patient group.
STUDY LIMITATIONS
The current study has limitations. First, all elderly
patients were unable to perform exercise testing reflect-
ing a high-risk population. The results of these study
may not be applicable to other elderly patients. Second,
no attenuation or scatter correction was used for MPI.
Application of attenuation and scatter correction may
have further improved the accuracy of SPECT MPI.22
Third, due to the elderly patient population studied, the
current results may not be extrapolated to younger
patients. Fourth, gated SPECT was not routinely used in
our laboratory at the time that this study was performed.
Previous data have demonstrated the superiority of gated
SPECT to non-gated SPECT in outcome prediction.
However, in the current study, we analyzed the prog-
nostic value of non-gated SPECT. Finally, the examined
patient population was relatively small. This could have
influenced the outcome of the multivariable analysis.
CONCLUSIONS
Dobutamine stress MPI provides incremental prog-
nostic information for the prediction of all-cause
mortality and cardiac events on the long-term outcome
in elderly patients unable to perform exercise testing.
Patients with a normal MPI have a favorable prognosis
of long-term outcome, in contrast to patients with an
abnormal study.
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